HUTCHMED (China) (HCM) Return on Sales (2015 - 2021)

HUTCHMED (China) (HCM) posted quarterly Return on Sales of 0.0% for Q4 2021, up 75.65% quarter-over-quarter from 0.01% in Q1 2021.

HUTCHMED (China) (HCM) Return on Sales (2015 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has reported Return on Sales for 6 consecutive years, with 0.0% the latest figure, recorded in Q4 2021.

In Q4 2021, Return on Sales changed N/A year-over-year to 0.0%; the TTM figure through Dec 2021 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.01%, up 4.0% from the prior year.
Return on Sales advanced to 0.0% in Q4 2021 per HCM's latest filing, from 0.01% in the prior quarter.
Across five years, Return on Sales topped out at 0.01% in Q2 2018 and bottomed at 0.02% in Q2 2019.
Historically, Return on Sales has averaged 0.0% across 4 years, with a median of 0.01% in 2018.
On a YoY basis, Return on Sales climbed as much as 1 bps in 2019 and fell as far as 3 bps in 2019.
HUTCHMED (China)'s Return on Sales stood at 0.0% in 2018, then tumbled by 270 bps to 0.01% in 2019, then slipped by 13 bps to 0.01% in 2020, then soared by 77 bps to 0.0% in 2021.
Business Quant data shows HCM's Return on Sales at 0.0% in Q4 2021, 0.01% in Q1 2021, and 0.01% in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	0.00%
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	0.00%
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	0.00%
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	0.00%
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	0.00%
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	0.00%
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	0.00%
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	HUTCHMED (China)	2.18 Bn	2.18 Bn	-	-

Download Data